Avalon Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Avalon Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-751	Closed	-$465K	–	149
2024 Q3	$465K	Buy	751 +354	+89%	+$210K	0.14%	84
2024 Q2	$220K	Buy	397 +51	+15%	+$29.2K	0.07%	113
2024 Q1	$201K	Buy	+346	New	+$194K	0.08%	95
2019 Q4	–	Sell	-5,275	Closed	-$1.54M	–	41
2019 Q3	$1.54M	Sell	5,275 -455	-8%	-$130K	1.82%	17
2019 Q2	$1.68M	Sell	5,730 -1,650	-22%	-$454K	1.92%	16
2019 Q1	$2.02M	Buy	7,380 +1,870	+34%	+$465K	1.71%	19
2018 Q4	$1.23M	Sell	5,510 -460	-8%	-$108K	1.31%	19
2018 Q3	$1.46M	Sell	5,970 -55	-0.9%	-$12.7K	1.33%	24
2018 Q2	$1.25M	Buy	+6,025	New	+$1.28M	1.24%	24

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Avalon Capital Management's TMO Position: Q4 2024 in Review

Avalon Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 751 shares — an estimated $465K sold.

Avalon Capital Management first reported a position in TMO in Q2 2018 and held it in 9 quarters. The position peaked at $2.02M in Q1 2019. 2,617 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

Avalon Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
Avalon Capital Management sold 751 Thermo Fisher Scientific shares in Q4 2024, an estimated $465K.
Avalon Capital Management first reported a position in Thermo Fisher Scientific in Q2 2018 and held it in 9 quarters.
Avalon Capital Management's Thermo Fisher Scientific position peaked at $2.02M in Q1 2019.
2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Avalon Capital Management's 13F filing for Q4 2024, filed 4 Feb 2025.